@Davidboon@stockrocket
I do not believe people are interpreting this correctly...
"Mesoblast being eligible to receive payments up to US$112.5 million prior to product launch in the EU, inclusive of US$17.5 million already received,..." as per bridog - I believe this means US$150M - US$17.5M (already received by MSB) = US$132.5M
As stockrock points out, the US$20 would be deducted due to not having to run a confirmatory trial in EU.
US$132.5M - US$20M = US$112.5M
Glad to be corrected.... So the upfront money has only been reduced by US$20M due to no EU trial (?)....
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-199
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |